日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

预测前列腺癌放射治疗的剂量反应:在随机 III 期 NRG/RTOG 0126 和 SAKK 09/10 试验中验证放射特征

Dal Pra, A; Ghadjar, P; Ryu, H M; Proudfoot, J A; Hayoz, S; Michalski, J M; Spratt, D E; Liu, Y; Schär, C; Berlin, A M; Zwahlen, D R; Simko, J P; Hölscher, T; Efstathiou, J A; Polat, B; Sandler, H M; Hildebrandt, G; Parliament, M B; Mueller, A-C; Dayes, I S; Plasswilm, L; Correa, R J M; Robertson, J M; Karrison, T G; Davicioni, E; Hall, W A; Feng, F Y; Pollack, A; Thalmann, G N; Nguyen, P L; Aebersold, D M; Tran, P T; Zhao, S G

Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant

早期外周血和骨髓微小残留病灶作为未接受移植的四联疗法治疗多发性骨髓瘤患者的预后标志物

Derman, Benjamin A; Cooperrider, Jennifer; Pula, Anna; Simmons, Heidi; Kubicki, Tadeusz; Zonder, Jeffrey; Afrough, Aimaz; Grinblatt, David; Rosenblatt, Jacalyn; Anderson, Larry D Jr; Kin, Andrew; Avigan, David; Narula, Sunil; Rayani, Shayan; Jiang, Ken; Major, Ajay; Karrison, Theodore; Jacob, Allison; Jakubowiak, Andrzej J

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL

一项多中心 I/II 期临床试验,研究来那度胺联合剂量调整的 EPOCH-R 方案治疗 MYC 相关弥漫性大 B 细胞淋巴瘤的疗效。

Cahill, Kirk; Godfrey, James; Nabhan, Chadi; Kline, Justin; Riedell, Peter A; Cohen, Kenneth S; Narula, Sunil; Karrison, Theodore G; Robertson, Jessica; Karmali, Reem; Venugopal, Parameswaran; Kim, Seo-Hyun; Rapoport, Aaron P; Lee, Seung Tae; Law, Jennie; Fishkin, Paul A S; Isufi, Iris; Velasco, Mario; Kaminer, Lynne; Smith, Sonali M

Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia

一项随机 II 期研究旨在评估单药纳武利尤单抗在维持急性髓系白血病缓解中的作用。

Pyzer, Athalia R; Dillon, Laura W; Sharon, Elad; Karrison, Theodore G; Zha, Yuanyuan; Fulton, Noreen; Gui, Gege; Andrew, Georgia; Streicher, Howard; Sweet, Kendra; Yaghmour, George; Liu, Jane Jijun; Jonas, Brian A; Schimmer, Aaron D; Grant, Steven; Zeidan, Amer M; Hildebrandt, Gerhard C; Lowrey, Christopher H; Mattison, Ryan J; Palmisiano, Neil; Salhotra, Amandeep; Tzachanis, Dimitrios; Baer, Maria R; Lin, Tara L; Patel, Prapti; Chen, Helen; Stadler, Walter M; Odenike, Olatoyosi; Larson, Richard A; Gajewski, Thomas F; Hourigan, Christopher S; Stock, Wendy; Liu, Hongtao

Impact of First-of-Its-Kind Patient-Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes

首个面向患者的药物遗传学工具对剂量决策和治疗结果的影响

Cho, Youngwoo; Elahi, Sami; Jack, Matthew M; Campbell, John; Smith, Emily; Knoebel, Randall W; George, David; House, Larry; Yeo, Kiang-Teck J; Karrison, Theodore; Volchenboum, Samuel L; Meltzer, David O; Szmulewitz, Russell Z; Vokes, Everett E; Ratain, Mark J; O'Donnell, Peter H

High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration

早期三阴性乳腺癌中肿瘤糖皮质激素受体高表达与 T 调节细胞浸润增加有关

Margarite D Matossian #, Christine Shiang #, Deniz Nesli Dolcen #, Marie Dreyer #, Ken Hatogai, Katie Hall, Poornima Saha #, Anna Biernacka, Randy F Sweis, Theodore Karrison, Nan Chen, Rita Nanda, Suzanne D Conzen

Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer

卡铂、吉西他滨和米非司酮用于治疗晚期乳腺癌和复发/持续性上皮性卵巢癌

Stringer-Reasor, Erica M; Saha, Poornima; Kocherginsky, Masha; Lastra, Ricardo; Baker, Gabrielle; Lenygel, Ernst; Karrison, Theodore; Olalde, Lauren; Mokrzycki, Elizabeth; Hahn, Olwen M; Hoffman, Philip C; Conzen, Suzanne D; Fleming, Gini F; Nanda, Rita

Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926

保留膀胱的三联疗法治疗高级别T1期膀胱癌:NRG Oncology/RTOG 0926 II期方案的结果

Dahl, Douglas M; Rodgers, Joseph P; Shipley, William U; Michaelson, M Dror; Wu, Chin-Lee; Parker, William; Jani, Ashesh B; Cury, Fabio L; Hudes, Richard S; Michalski, Jeff M; Hartford, Alan C; Song, Daniel; Citrin, Deborah E; Karrison, Theodore G; Sandler, Howard M; Feng, Felix Y; Efstathiou, Jason A

Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perils

在神经肿瘤学试验的设计和分析中利用外部对照数据:经验与风险

Polley, Mei-Yin C; Schwartz, Daniel; Karrison, Theodore; Dignam, James J

Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant

一项针对未接受移植的新诊断多发性骨髓瘤患者的达雷妥尤单抗、卡非佐米、来那度胺和地塞米松联合治疗的II期临床试验的最终分析

Derman, Benjamin A; Cooperrider, Jennifer; Rosenblatt, Jacalyn; Avigan, David E; Rampurwala, Murtuza; Barnidge, David; Major, Ajay; Karrison, Theodore; Jiang, Ken; Ramsland, Aubrianna; Kubicki, Tadeusz; Jakubowiak, Andrzej J